SGLT2抑制剂和GLP-1 RAs在2型糖尿病和心血管疾病、慢性肾脏疾病和肥胖合并症患者中的处方模式

{"title":"SGLT2抑制剂和GLP-1 RAs在2型糖尿病和心血管疾病、慢性肾脏疾病和肥胖合并症患者中的处方模式","authors":"","doi":"10.17756/jocd.2022-050","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":87308,"journal":{"name":"Journal of obesity and chronic diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prescribing Patterns of SGLT2 Inhibitors and GLP-1 RAs in Patients with Type 2 Diabetes and Comorbid Conditions of Cardiovascular Disease, Chronic Kidney Disease, and Obesity\",\"authors\":\"\",\"doi\":\"10.17756/jocd.2022-050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":87308,\"journal\":{\"name\":\"Journal of obesity and chronic diseases\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of obesity and chronic diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17756/jocd.2022-050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of obesity and chronic diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17756/jocd.2022-050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}